Vaxart Statistics
Share Statistics
Vaxart has 227.48M shares outstanding. The number of shares has increased by 30.84% in one year.
| Shares Outstanding | 227.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 225.47M |
| Failed to Deliver (FTD) Shares | 19.23K |
| FTD / Avg. Volume | 1.27% |
Short Selling Information
The latest short interest is 11.27M, so 4.96% of the outstanding shares have been sold short.
| Short Interest | 11.27M |
| Short % of Shares Out | 4.96% |
| Short % of Float | 5% |
| Short Ratio (days to cover) | 11.71 |
Valuation Ratios
The PE ratio is -1.01 and the forward PE ratio is -1.78.
| PE Ratio | -1.01 |
| Forward PE | -1.78 |
| PS Ratio | 11.24 |
| Forward PS | 5.1 |
| PB Ratio | 1.44 |
| P/FCF Ratio | -1.15 |
| PEG Ratio | n/a |
Enterprise Valuation
Vaxart Inc. has an Enterprise Value (EV) of 74.71M.
| EV / Earnings | -0.91 |
| EV / Sales | 10.12 |
| EV / EBITDA | -1.04 |
| EV / EBIT | -0.9 |
| EV / FCF | -1.03 |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.32 |
| Quick Ratio | 3.32 |
| Debt / Equity | 0.11 |
| Total Debt / Capitalization | 10 |
| Cash Flow / Debt | -10.96 |
| Interest Coverage | -57.6 |
Financial Efficiency
Return on equity (ROE) is -1.43% and return on capital (ROIC) is -99.16%.
| Return on Equity (ROE) | -1.43% |
| Return on Assets (ROA) | -0.9% |
| Return on Capital (ROIC) | -99.16% |
| Revenue Per Employee | 67.70K |
| Profits Per Employee | -756.56K |
| Employee Count | 109 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 261.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 46.49% in the last 52 weeks. The beta is 0.7, so Vaxart 's price volatility has been higher than the market average.
| Beta | 0.7 |
| 52-Week Price Change | 46.49% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.78 |
| Relative Strength Index (RSI) | 68.97 |
| Average Volume (20 Days) | 1.51M |
Income Statement
In the last 12 months, Vaxart had revenue of 7.38M and earned -82.47M in profits. Earnings per share was -0.57.
| Revenue | 7.38M |
| Gross Profit | -60.76M |
| Operating Income | -83.35M |
| Net Income | -82.47M |
| EBITDA | -72.13M |
| EBIT | -83.35M |
| Earnings Per Share (EPS) | -0.57 |
Balance Sheet
The company has 34.76M in cash and 26.51M in debt, giving a net cash position of 8.24M.
| Cash & Cash Equivalents | 34.76M |
| Total Debt | 26.51M |
| Net Cash | 8.24M |
| Retained Earnings | -409.57M |
| Total Assets | 166.67M |
| Working Capital | -13.91M |
Cash Flow
In the last 12 months, operating cash flow was -70.45M and capital expenditures -1.87M, giving a free cash flow of -72.32M.
| Operating Cash Flow | -70.45M |
| Capital Expenditures | -1.87M |
| Free Cash Flow | -72.32M |
| FCF Per Share | -0.5 |
Margins
Gross margin is -82.35K%, with operating and profit margins of -112.95K% and -111.76K%.
| Gross Margin | -82.35K% |
| Operating Margin | -112.95K% |
| Pretax Margin | -111.40K% |
| Profit Margin | -111.76K% |
| EBITDA Margin | -977.54% |
| EBIT Margin | -1.13K% |
| FCF Margin | -980.13% |
Dividends & Yields
VXRT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -67.86% |
| FCF Yield | -38.04% |
Analyst Forecast
The average price target for VXRT is $3, which is 257.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $3 |
| Price Target Difference | 257.1% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Feb 14, 2018. It was a backward split with a ratio of 1:11.
| Last Split Date | Feb 14, 2018 |
| Split Type | backward |
| Split Ratio | 1:11 |
Scores
| Altman Z-Score | -4.44 |
| Piotroski F-Score | 3 |